Two infants exposed to anti-TNFα monotherapy (1 discontinued at week 30, 1 continued throughout pregnancy), had one event of pneumonia, and one was clinically diagnosed with pertussis despite immunizations, at age 10 months. Here, TNF is linked to susceptibility to pneumonia measurement.